Latest Oncology Stories
- Discuss interim results for Study 202 evaluating PEGPH20 with gemcitabine and ABRAXANE® in pancreatic cancer patients - SAN DIEGO, Jan.
Study to focus on mutations and deletions of CREBBP and EP300 genes in lymphomas SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc.
NiCord® is in clinical development as a treatment for blood cancers including leukemia and lymphoma JERUSALEM, January 6, 2015 /PRNewswire/ -- Gamida Cell [http://www.gamida-cell.com
Aldoxorubicin Shows a Complete Response, Tumor Shrinkage, Prolonged Stable Disease, and Favorable Tolerability in Patients LOS ANGELES, Jan.
New IMBRUVICA Data from National Institutes of Health Study Published in The Lancet Oncology SUNNYVALE, Calif., Jan. 5, 2015 /PRNewswire/ -- Pharmacyclics, Inc.
The Mesothelioma Victims Center is sharing a list of current nuclear power plants operating in the United States and urges anyone diagnosed with mesothelioma who worked at one of these facilities to
- totally perplexed and mixed up.